Leadership evolution is a journey of continuous learning and adaptation. This article explores how leaders have transformed ...

SemiQ has released three 1.2kV three-phase silicon carbide mosfet bridges in 62.8 x 33.8 x 15mm press-fit six-pack modules. SemiQ has released three 1.2kV three-phase silicon carbide mosfet bridges in ...

BSEB Teacher Competency Test 2025: The timetable for the Phase 3, 4, and 5 Teacher Competency Test 2025 has been released by the Bihar School Examination Board (BSEB) on April 26, 2025.

The phase 3 trial enrolled 1033 patients who had not received prior chemotherapy for mCRPC and had evidence of disease progression despite androgen deprivation therapy (ADT). Study participants ...

That's because it is already in the process of running the ongoing phase 3 LEVEL study and is set to begin the second phase 3 study soon in 2025. Both of these late-stage studies are using this ...

The Swiss drugmaker is making the outlay, around half of which is upfront, to buy Regulus Therapeutics for a rare renal disease drug that is set to enter phase 3 in the third quarter. Regulus ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. The phase 3 study linked the oral GLP-1 drug orforglipron to similar reductions in blood glucose and body ...

May 4 - Xander Bogaerts had two hits and three RBI to lead the San Diego Padres to a 4-0 victory over the host Pittsburgh Pirates on Sunday afternoon. Bogaerts drove in all three runs off Pirates ...

Tamil Nadu Deputy Chief Minister Udhayanidhi Stalin on Thursday (May 1, 2025) inaugurated the work on the third phase of the Chennai Peripheral Ring Road project (CPRR), undertaken by the State ...

Dräger, a global leader in safety technology, proudly announces the launch of the Alcotest 7000?an innovative alcohol ...

Phase One of the project enabled three wind turbines to be operational from August 2007, and Phase Two saw a further three turbines online in February 2010. These six turbines at Sand Bay, are due ...

A phase 3 trial in metastatic melanoma is ongoing, with a Biologics License Application expected by year-end. The vaccines offer a novel approach by targeting the entire tumor environment ...